Back
Brookfield Asset Management Vs. Xtacy Therapeutics Industry Stock Comparison
Buy
77
BAM.TO
Brookfield Asset Management
Last Price:
64.66
Seasonality Move:
2.28%
Sell
20
XTCY.CX
Xtacy Therapeutics
Last Price:
0.02
Seasonality Move:
43.46%
Buy
77
Brookfield Asset Management (BAM.TO)
is a Buy
Is Brookfield Asset Management a Buy, Sell or Hold?
- The current Brookfield Asset Management [BAM.TO] share price is $62.17. The Score for BAM.TO is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- BAM.TO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
Xtacy Therapeutics (XTCY.CX)
is a Sell
Is Xtacy Therapeutics a Buy, Sell or Hold?
- The current Xtacy Therapeutics [XTCY.CX] share price is $0.02. The Score for XTCY.CX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- XTCY.CX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
BAM.TO Stock Price Chart
What is Brookfield Asset Management's stock price today?
-
The Brookfield Asset Management share price today is $62.17
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BAM.TO is experiencing slight buying pressure.
XTCY.CX Stock Price Chart
What is Xtacy Therapeutics's stock price today?
-
The Xtacy Therapeutics share price today is $0.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTCY.CX is experiencing slight buying pressure.
BAM.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.61 | Buy |
| Relative Strength Index (14 RSI): | 74.75 | Buy |
| Chaikin Money Flow: | 58791 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.48 - 59.52) | Buy |
| Bollinger Bands (100): | (52.53 - 57.47) | Buy |
XTCY.CX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 38.74 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.02 - 0.04) | Sell |
| Bollinger Bands (100): | (0.03 - 0.05) | Sell |
BAM.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.32 | Buy |
| 20-day SMA: | 57.35 | Buy |
| 50-day SMA: | 56.65 | Buy |
| 200-day SMA: | 54.4 | Buy |
| 8-day EMA: | 60.34 | Buy |
| 20-day EMA: | 58.32 | Buy |
| 50-day EMA: | 56.69 | Buy |
| 200-day EMA: | 53.6 | Buy |
XTCY.CX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.03 | Sell |
| 20-day SMA: | 0.03 | Sell |
| 50-day SMA: | 0.04 | Sell |
| 200-day SMA: | 0.04 | Sell |
| 8-day EMA: | 0.03 | Sell |
| 20-day EMA: | 0.03 | Sell |
| 50-day EMA: | 0.03 | Sell |
| 200-day EMA: | 0.05 | Sell |
Brookfield Asset Management Earnings Growth & BAM.TO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.09 per share, an increase this year of $0.08 per share, and an increase next year of $0.36 per share.
Xtacy Therapeutics Earnings Growth & XTCY.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Brookfield Asset Management Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Xtacy Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||